Rokson Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -45.49%
(FY 2022)
- Profit 77.12%
(FY 2022)
- Ebitda 88.07%
(FY 2022)
- Net Worth -2.61%
(FY 2022)
- Total Assets -97.37%
(FY 2022)
About Rokson Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Mishra and Poonam Mishra serve as directors at the Company.
- CIN/LLPIN
U24230MH2011PTC213998
- Company No.
213998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rokson Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Mishra  | Director | 24-Feb-2011 | Current |
| Poonam Mishra | Director | 24-Feb-2011 | Current |
Financial Performance and Corporate Structure Insights of Rokson Pharmaceuticals.
Rokson Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.49% decrease. The company also saw a substantial improvement in profitability, with a 77.12% increase in profit. The company's net worth dipped by a decrease of 2.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rokson Pharmaceuticals?
In 2020, Rokson Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prithvi International Private LimitedActive 15 years 11 months
Sunil Mishra and Poonam Mishra are mutual person
- Paras Venture Private LimitedActive 14 years 4 months
Sunil Mishra and Poonam Mishra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rokson Pharmaceuticals?
Unlock and access historical data on people associated with Rokson Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rokson Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rokson Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
